EastHORN is a Contract Research Organization dedicated to conducting Phase I-IV clinical trials in Central and Eastern Europe. The company was seeking to refresh it's branding and web-presence, while reinforicing their unique familiarity with the Central and Eastern European target markets.
Axxiem designed a new website that built on the company's existing brand identity and colors. Navigation on the homepage is comprised of large panoramic images that appear when a vistor hovers their mouse over a link, also providing direct access to sub-pages. Axxiem produced an interactive map module for the Geographical Reach area if the site, which also includes dedicated pages for many of the countries EastHORN serves. These pages feature country-specific images and relevant clinical trial information for potential clients.
EnduRx Pharmaceuticals is a late pre-clinical stage pharmaceutical company developing a transformative tumor and cardiovascular targeting platform technology. A key challenge was to present the company's sophisticated subject matter in an approachable and attractive manner. The EnduRx technology was invented by world-renowned scientist Dr. Erkki Ruoslahti at the Sanford-Burnham Medical Research Institute in California, and has demonstrated proof of concept in pre-clinical studies.
Axxiem delivered a clear and contemporary site design along with supporting graphic materials to help convey key messaging. Additional assets produced include a compelling Product Pipeline graphic, a narrative slideshow module, and a company overview video shot on site at Sanford-Burnham Medical Research Institute. Axxiem handled all shooting, editing and production for the video piece.
Catalyst Pharmaceutical Partners, Inc., is a specialty pharmaceutical company focused on in-licensing, developing and commercializing novel prescription drugs to treat rare (orphan) neurological diseases and disorders. Catalyst is an established public company that was looking for website redesign while preserving existing branding and corporate identity. The desire for a new website also coincided with a shift in the companys target therapeutic areas, requiring adjustments to overall messaging and content.
Consulting with the firm to fully understand their new directions, Axxiem designed a new site keeping a solid connection with the brand while representing some very new directions for the firm. The new site has a fresh and contemporary feel, and uses warm imagery to welcome the visitors. The project also included integration with Investor Relations services provided by Shareholder.com.
A startup with some amazing technology, Axxiem was challenged to present the company and its opportunity staying within the constraints of a limited marketing budget.
A small but powerful site delivers a strong story, including Presentation and video of the firm's work, pipeline and market opportunities.